Clinical on-site monitoring of ß-lactam antibiotics for a personalized antibiotherapy

Abstract An appropriate antibiotherapy is crucial for the safety and recovery of patients. Depending on the clinical conditions of patients, the required dose to effectively eradicate an infection may vary. An inadequate dosing not only reduces the efficacy of the antibiotic, but also promotes the e...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: R. Bruch, C. Chatelle, A. Kling, B. Rebmann, S. Wirth, S. Schumann, W. Weber, C. Dincer, G. Urban
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2017
Materias:
R
Q
Acceso en línea:https://doaj.org/article/bc35e50ee17a4018acd7b593716960cb
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:bc35e50ee17a4018acd7b593716960cb
record_format dspace
spelling oai:doaj.org-article:bc35e50ee17a4018acd7b593716960cb2021-12-02T15:05:09ZClinical on-site monitoring of ß-lactam antibiotics for a personalized antibiotherapy10.1038/s41598-017-03338-z2045-2322https://doaj.org/article/bc35e50ee17a4018acd7b593716960cb2017-06-01T00:00:00Zhttps://doi.org/10.1038/s41598-017-03338-zhttps://doaj.org/toc/2045-2322Abstract An appropriate antibiotherapy is crucial for the safety and recovery of patients. Depending on the clinical conditions of patients, the required dose to effectively eradicate an infection may vary. An inadequate dosing not only reduces the efficacy of the antibiotic, but also promotes the emergence of antimicrobial resistances. Therefore, a personalized therapy is of great interest for improved patients’ outcome and will reduce in long-term the prevalence of multidrug-resistances. In this context, on-site monitoring of the antibiotic blood concentration is fundamental to facilitate an individual adjustment of the antibiotherapy. Herein, we present a bioinspired approach for the bedside monitoring of free accessible ß-lactam antibiotics, including penicillins (piperacillin) and cephalosporins (cefuroxime and cefazolin) in untreated plasma samples. The introduced system combines a disposable microfluidic chip with a naturally occurring penicillin-binding protein, resulting in a high-performance platform, capable of gauging very low antibiotic concentrations (less than 6 ng ml−1) from only 1 µl of serum. The system’s applicability to a personalized antibiotherapy was successfully demonstrated by monitoring the pharmacokinetics of patients, treated with ß-lactam antibiotics, undergoing surgery.R. BruchC. ChatelleA. KlingB. RebmannS. WirthS. SchumannW. WeberC. DincerG. UrbanNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 7, Iss 1, Pp 1-10 (2017)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
R. Bruch
C. Chatelle
A. Kling
B. Rebmann
S. Wirth
S. Schumann
W. Weber
C. Dincer
G. Urban
Clinical on-site monitoring of ß-lactam antibiotics for a personalized antibiotherapy
description Abstract An appropriate antibiotherapy is crucial for the safety and recovery of patients. Depending on the clinical conditions of patients, the required dose to effectively eradicate an infection may vary. An inadequate dosing not only reduces the efficacy of the antibiotic, but also promotes the emergence of antimicrobial resistances. Therefore, a personalized therapy is of great interest for improved patients’ outcome and will reduce in long-term the prevalence of multidrug-resistances. In this context, on-site monitoring of the antibiotic blood concentration is fundamental to facilitate an individual adjustment of the antibiotherapy. Herein, we present a bioinspired approach for the bedside monitoring of free accessible ß-lactam antibiotics, including penicillins (piperacillin) and cephalosporins (cefuroxime and cefazolin) in untreated plasma samples. The introduced system combines a disposable microfluidic chip with a naturally occurring penicillin-binding protein, resulting in a high-performance platform, capable of gauging very low antibiotic concentrations (less than 6 ng ml−1) from only 1 µl of serum. The system’s applicability to a personalized antibiotherapy was successfully demonstrated by monitoring the pharmacokinetics of patients, treated with ß-lactam antibiotics, undergoing surgery.
format article
author R. Bruch
C. Chatelle
A. Kling
B. Rebmann
S. Wirth
S. Schumann
W. Weber
C. Dincer
G. Urban
author_facet R. Bruch
C. Chatelle
A. Kling
B. Rebmann
S. Wirth
S. Schumann
W. Weber
C. Dincer
G. Urban
author_sort R. Bruch
title Clinical on-site monitoring of ß-lactam antibiotics for a personalized antibiotherapy
title_short Clinical on-site monitoring of ß-lactam antibiotics for a personalized antibiotherapy
title_full Clinical on-site monitoring of ß-lactam antibiotics for a personalized antibiotherapy
title_fullStr Clinical on-site monitoring of ß-lactam antibiotics for a personalized antibiotherapy
title_full_unstemmed Clinical on-site monitoring of ß-lactam antibiotics for a personalized antibiotherapy
title_sort clinical on-site monitoring of ß-lactam antibiotics for a personalized antibiotherapy
publisher Nature Portfolio
publishDate 2017
url https://doaj.org/article/bc35e50ee17a4018acd7b593716960cb
work_keys_str_mv AT rbruch clinicalonsitemonitoringofßlactamantibioticsforapersonalizedantibiotherapy
AT cchatelle clinicalonsitemonitoringofßlactamantibioticsforapersonalizedantibiotherapy
AT akling clinicalonsitemonitoringofßlactamantibioticsforapersonalizedantibiotherapy
AT brebmann clinicalonsitemonitoringofßlactamantibioticsforapersonalizedantibiotherapy
AT swirth clinicalonsitemonitoringofßlactamantibioticsforapersonalizedantibiotherapy
AT sschumann clinicalonsitemonitoringofßlactamantibioticsforapersonalizedantibiotherapy
AT wweber clinicalonsitemonitoringofßlactamantibioticsforapersonalizedantibiotherapy
AT cdincer clinicalonsitemonitoringofßlactamantibioticsforapersonalizedantibiotherapy
AT gurban clinicalonsitemonitoringofßlactamantibioticsforapersonalizedantibiotherapy
_version_ 1718388918756311040